This inventor holds 1 USPTO granted patent. Top assignee: Oriental Yeast Co., Ltd.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Taizou Hayashi: Innovator in Cerebral Apoplexy Diagnosis
Introduction
Taizou Hayashi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of cerebral apoplexy. His innovative work has led to the development of a novel marker that aids in the diagnosis of this critical condition.
Latest Patents
Hayashi holds a patent for a "Marker for Cerebral Apoplexy." This invention involves treating a sample with a phosphoglyceric acid mutase (PGAM) inhibitor, specifically polythionic acid salts such as potassium tetrathionate. This process inactivates the M-type isozyme activity, allowing for the quantification of the B-type PGAM through a rate assay. The B-type PGAM serves as a novel marker for cerebral apoplexy, enabling accurate diagnosis through its assay.
Career Highlights
Taizou Hayashi is associated with Oriental Yeast Co., Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical diagnostics and patient care.
Collaborations
Hayashi collaborates with notable colleagues, including Takekazu Horio and Yasutaka Kaneda. Their combined expertise contributes to the ongoing development of innovative solutions in the medical field.
Conclusion
Taizou Hayashi's contributions to the diagnosis of cerebral apoplexy through his innovative patent highlight the importance of research and development in medical science. His work exemplifies the potential of inventions to improve healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile